| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/19/2009 | CA2458872C Human ubiquitin-conjugating enzyme |
| 05/19/2009 | CA2387247C Use of neutralizing agents to growth factors for reducing wound scarring |
| 05/19/2009 | CA2367955C Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/19/2009 | CA2318029C Apo-2 ligand |
| 05/19/2009 | CA2239490C Preparation of a multicombinatorial library of antibody gene expression vectors |
| 05/14/2009 | WO2009062081A2 Methods and compositions for antibody or vaccine therapy |
| 05/14/2009 | WO2009062051A2 Methods and compositions for antibody therapy |
| 05/14/2009 | WO2009062050A2 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 05/14/2009 | WO2009061996A2 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 05/14/2009 | WO2009061910A1 Anti-factor b antibodies and their uses |
| 05/14/2009 | WO2009061739A1 Neutralization of hcv |
| 05/14/2009 | WO2009061215A1 Compositions and methods for altering pigment production in plants |
| 05/14/2009 | WO2009060198A1 Anti-vegf antibody compositions and methods |
| 05/14/2009 | WO2009060129A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes |
| 05/14/2009 | WO2009060112A1 Pharmaceutical composition for cancer treatment |
| 05/14/2009 | WO2009039337A3 Inhibition of angiogenesis |
| 05/14/2009 | WO2009034473A3 Gas57 mutant antigens and gas57 antibodies |
| 05/14/2009 | WO2009029132A3 Antigen-binding proteins targeting s. aureus orf0657n |
| 05/14/2009 | WO2009021295A3 Inhibition of alpha synuclein toxicity |
| 05/14/2009 | WO2009013620A3 Homologous recombination |
| 05/14/2009 | WO2008154251A3 C3b antibodies and methods for the prevention and treatment of complement- associated disorders |
| 05/14/2009 | WO2008140493A3 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof |
| 05/14/2009 | WO2008097461A3 Hepcidin and hepcidin antibodies |
| 05/14/2009 | WO2008076379A8 Human antibodies to human delta like ligand 4 |
| 05/14/2009 | WO2008035216A3 Generation of heavy-chain only antibodies in transgenic animals |
| 05/14/2009 | WO2007056043A3 Use of potassium channels for identifying compounds that have an insecticidal effect |
| 05/14/2009 | WO2007001399A3 Compositions, splice variants and methods relating to cancer specific genes and proteins |
| 05/14/2009 | US20090126041 Regeneration |
| 05/14/2009 | US20090124793 Corticotropin releasing factor 2 receptor agonists |
| 05/14/2009 | US20090124792 Fluorescent polymethine cyanine dyes |
| 05/14/2009 | US20090124791 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens |
| 05/14/2009 | US20090124780 Nanoparticle chains and Preparation Thereof |
| 05/14/2009 | US20090124511 Antibody complexes and methods for immunolabeling |
| 05/14/2009 | US20090124023 Reagens for the Detection of Protein Acetylation Signaling Pathways |
| 05/14/2009 | US20090124022 Antibodies that bind to mammalian ngal and uses thereof |
| 05/14/2009 | US20090123953 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same |
| 05/14/2009 | US20090123948 highly sensitive enzyme immunoassay (EIA) for measuring IgG antibody against extracellular protein kinase A (ECPKA) |
| 05/14/2009 | US20090123943 Characterization and Identification of Unique Human Adiponectin Isoforms and Antibodies |
| 05/14/2009 | US20090123940 Molecules involved in synaptogenesis and uses therefor |
| 05/14/2009 | US20090123936 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 05/14/2009 | US20090123487 Precursors and enzymes associated with post translational modification of proteins implicated in isoform generation of PCNA |
| 05/14/2009 | US20090123484 Methods for Diagnosing and Treating Kidney Cancer |
| 05/14/2009 | US20090123483 Anti-ccr7 receptor antibodies for the treatment of cancer |
| 05/14/2009 | US20090123482 Assays for determining compounds which modulate tram phosphorylation |
| 05/14/2009 | US20090123481 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 05/14/2009 | US20090123479 Immunoglobulins |
| 05/14/2009 | US20090123478 Human antibody molecules for IL-13 |
| 05/14/2009 | US20090123477 Antibodies |
| 05/14/2009 | US20090123476 Targeted binding agents directed to upar and uses thereof |
| 05/14/2009 | US20090123475 for isolation of DNA encoding anti-Rh(D) antibodies; isolation of DNA encoding antibodies directed against any red blood cells antigen or other cell antigen; for typing platelets by generating phage antibodies specific for a number of clinically important platelet antigens |
| 05/14/2009 | US20090123473 Human bnp immunospecific antibodies |
| 05/14/2009 | US20090123472 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 05/14/2009 | US20090123470 Antibodies Against Cancer |
| 05/14/2009 | US20090123469 Anti-factor B antibodies and their uses |
| 05/14/2009 | US20090123468 Transducible polypeptides for modifying metabolism |
| 05/14/2009 | US20090123467 Polypeptide-Nucleic Acid Conjugate for Immunoprophylaxis or Immunotherapy for Neoplastic or Infectious Disorders |
| 05/14/2009 | US20090123466 Anti-cd40 monoclonal antibody |
| 05/14/2009 | US20090123462 Fgfr agonists |
| 05/14/2009 | US20090123461 Human podocalyxin alternative-spliced forms and uses thereof |
| 05/14/2009 | US20090123459 Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease |
| 05/14/2009 | US20090123456 determining whether an antibody is an agonist selective for nicotinic receptors, inhibits release of a proinflammatory cytokine from a mammalian cell, and if the antibody is reactive with nicotinic receptors; drug screening |
| 05/14/2009 | US20090123421 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 05/14/2009 | CA2743032A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes |
| 05/14/2009 | CA2706700A1 Compositions and methods for generating antibodies |
| 05/14/2009 | CA2705152A1 Anti-vegf antibody compositions and methods |
| 05/14/2009 | CA2705105A1 Pharmaceutical composition for cancer treatment |
| 05/14/2009 | CA2704973A1 Anti-factor b antibodies and their uses |
| 05/14/2009 | CA2704583A1 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 05/13/2009 | EP2058400A1 Protein/(poly)peptide libraries |
| 05/13/2009 | EP2058334A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 05/13/2009 | EP2058333A2 Anti-CCR2 antibodies and methods of use therefor |
| 05/13/2009 | EP2058332A1 Use of CD25 binding molecules in steroid-resistant patients |
| 05/13/2009 | EP2058327A2 Genes encoding insect odorant receptors and uses thereof |
| 05/13/2009 | EP2058006A1 Anti-CCR5 antibody |
| 05/13/2009 | EP2057999A2 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 05/13/2009 | EP2057466A2 Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy |
| 05/13/2009 | EP2057194A2 Engineered anti-il-23r antibodies |
| 05/13/2009 | EP2057193A2 Ephb3-specific antibody and uses thereof |
| 05/13/2009 | EP2057192A2 Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof |
| 05/13/2009 | EP2057191A1 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling |
| 05/13/2009 | EP2057190A2 Anti-interferon alpha monoclonal antibodies and methods for use |
| 05/13/2009 | EP2056874A1 Tumor therapy with an anti-vegf antibody |
| 05/13/2009 | EP2056869A2 Dual variable domain immunoglobulin and uses thereof |
| 05/13/2009 | EP2056860A2 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof |
| 05/13/2009 | EP2056849A2 Methods and compositions for treating ige-mediated diseases |
| 05/13/2009 | EP2056838A2 Combination therapy for treatment of immune disorders |
| 05/13/2009 | EP1963367A4 Polishing steps used in multi-step protein purification processes |
| 05/13/2009 | EP1848804A4 Anti-muci alpha beta antibodies |
| 05/13/2009 | EP1771549B1 Method for isolating and culturing neural stem cells |
| 05/13/2009 | EP1605058B1 Method of screening light chain of antibody light chains |
| 05/13/2009 | EP1581759B1 Methods for treating taxol-induced sensory neuropathy |
| 05/13/2009 | EP1495325B1 Use of nucloeoside derivatives comprising a citrate group for producing antibodies having affinity for triphosphorylated nucleosides and uses thereof |
| 05/13/2009 | EP1485477B1 Novel type-1 cytokine receptor glm-r |
| 05/13/2009 | EP1485407B1 A mutated immunoglobulin-binding protein |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | EP1309692B1 Anti-il-12 antibodies, compositions, methods and uses |
| 05/13/2009 | EP1294891B1 Transport peptides derived from erns protein |
| 05/13/2009 | EP1105498B1 Hiv vaccine |
| 05/13/2009 | EP0914325B1 Modulators of the function of fas receptors and other proteins |
| 05/13/2009 | CN101432422A Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |